Stylus Medicine is a biotechnology company dedicated to developing transformative in vivo genetic medicines to unlock cures. Stylus combines engineered recombinases with non-viral delivery to specifically encode therapeutics.
Market
Genetic Medicines
Location
Cambridge,
MA,
USA
Coinvestors
RA Capital Management, Khosla Ventures, Chugai Venture Fund, Eli Lilly and Company, Johnson & Johnson Innovation - JJDC